Conformation changes of p53 proteins in regulation of murine T lymphocyte proliferation - PubMed

Affiliations

• PMID: 8287068

Conformation changes of p53 proteins in regulation of murine T lymphocyte proliferation

J Wu et al. Cell Mol Biol Res. 1993.

Abstract

This report shows that p53 gene expression is required for proliferation of Concanavalin A (ConA)-stimulated murine T lymphocytes. p53 gene-specific antisense oligodeoxynucleotides strongly inhibited expression of p53 gene in T lymphocytes, causing suppression of ConA-induced cell proliferation. In contrast, the complementary-sense oligomers had no inhibitory effects. Northern and immunoprecipitation-blotting assay data, however, showed no change in p53 mRNA and proteins synthesized in T lymphocytes before and after ConA stimulation. p53 proteins in the resting and ConA-stimulated T cells had different immunoreactivity with specific monoclonal antibodies. p53 from resting T cells only reacted with "wild-type form" p53-specific monoclonal antibody (PAb246); whereas, p53 from ConA-stimulated T cells was recognized by "mutant-form" p53-specific monoclonal antibody (PAb421). These results suggest that the conformation of p53 proteins in resting and ConA-stimulated T cells are different. The p53 conformation changes may be related to the regulation of murine T lymphocyte proliferation.

Similar articles

• Conformational analysis of p53 in resting and concanavalin A-stimulated mouse lymphocytes.

  Mosner J, Deppert W. Mosner J, et al. Oncogene. 1992 Apr;7(4):661-6. Oncogene. 1992. PMID: 1565465

• [Effects of Hesperetin on cell activation and proliferation of murine T lymphocytes in vitro].

  Zhou YY, Zeng YY, Huang XY, Song B. Zhou YY, et al. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2009 Apr;25(4):315-8. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2009. PMID: 19351499 Chinese.

• [The effect of morin on activation, proliferation and cell-cycle of murine T lymphocytes in vitro].

  Zang N, Zeng YY, Huang XY, Wang T, Ye XY, Zhou JG, Wang HY. Zang N, et al. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2007 Mar;23(3):197-200. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2007. PMID: 17343781 Chinese.

• Forms and functions of p53.

  Milner J. Milner J. Semin Cancer Biol. 1994 Jun;5(3):211-9. Semin Cancer Biol. 1994. PMID: 7948949 Review.

Cited by

• Pharmacological reactivation of p53 in the era of precision anticancer medicine.

  Tuval A, Strandgren C, Heldin A, Palomar-Siles M, Wiman KG. Tuval A, et al. Nat Rev Clin Oncol. 2024 Feb;21(2):106-120. doi: 10.1038/s41571-023-00842-2. Epub 2023 Dec 15. Nat Rev Clin Oncol. 2024. PMID: 38102383 Review.

• A possible screening test for inherited p53-related defects based on the apoptotic response of peripheral blood lymphocytes to DNA damage.

  Camplejohn RS, Perry P, Hodgson SV, Turner G, Williams A, Upton C, MacGeoch C, Mohammed S, Barnes DM. Camplejohn RS, et al. Br J Cancer. 1995 Sep;72(3):654-62. doi: 10.1038/bjc.1995.390. Br J Cancer. 1995. PMID: 7669577 Free PMC article.

• Understanding p53 functions through p53 antibodies.

  Sabapathy K, Lane DP. Sabapathy K, et al. J Mol Cell Biol. 2019 Apr 1;11(4):317-329. doi: 10.1093/jmcb/mjz010. J Mol Cell Biol. 2019. PMID: 30907951 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal